Per Bernell

Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol

Nina Toft, Henrik Birgens, Jonas Abrahamsson et al. · European Journal Of Haematology · 2013 · 138 citations

Medicine, Oncology, Pediatrics +6

Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

Michael Grövdal, Mohsen Karimi, Rasheed Khan et al. · British Journal of Haematology · 2010 · 60 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

Michael Grövdal, Rasheed Khan, Anni Aggerholm et al. · Clinical Cancer Research · 2007 · 55 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.

Per Bernell, B Jacobsson, Ann Nordgren et al. · PubMed · 1996 · 48 citations

Life Sciences, Genetics, Hematology +13

Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes

Jonas Wallvik, Leif Stenke, Per Bernell et al. · European Journal Of Haematology · 2002 · 42 citations

Medicine, Hematology, Pharmacotherapy +11